Belton Regional Medical Center is proud to be part of the Sarah Cannon Cancer Institute HCA Midwest Health cancer network, providing local access to innovative clinical research trials, tumor profiling and genetic counseling; you can receive top cancer care in the comfort of your community hospital.
Sarah Cannon Cancer Institute offers a comprehensive array of diagnostic services such as minimally-invasive technology for diagnosing and treating breast lesions, as well as a range of cancer care services from screenings, cancer treatment and survivorship. The site is staffed by skilled oncology nurses who provide a wide variety of oncology and infusion services.
Sarah Cannon Cancer Institute builds on the current cancer program with genetic counseling services, nurse navigation programs, access to national clinical research trials and personalized medicine/tumor profiling.
Free Risk Assessments
Eating right and exercising are great steps toward leading a healthy life, but did you know your family history, age, and countless other factors can still put you at risk for health problems? Try our free risk assessments below to estimate your personal risk of developing breast, colon or rectal cancer, and identify your different types of risk factors.
For more information, contact us at (816) 348-1900 or visit hcamidwest.com. In addition to comprehensive prevention tools, diagnostics, cutting-edge therapies and surgical treatments, Sarah Cannon Cancer Institute HCA Midwest Health also offers a cancer wellness program to help support you every step of the way.
The Belton Regional Medical Center cancer program is accredited by the American College of Surgeons, Commission on Cancer (CoC). The CoC publishes the Cancer Programs Practice Profile Reports (CP3R) which includes a quality improvement measure for non-small cell lung cancer.
The (CP³R) measurement helps facilities to:
- Ensure patients are treated according to recognized standards of care,
- Promote quality improvement activities, and
- Accurately compare clinical performance among CoC accredited cancer programs.
Our most current results for the Non-small cell lung cancer measure:
|Measure Comparison||Belton Regional Medical Center||Missouri||National|
|Surgery is not the first course of treatment for AJCC* Stage of cN2, M0 non-small cell lung cases.||100%||88.4%||90.2%|
* American Joint Committee on Cancer